NYSE ARCA | ETF
The fund invests primarily in equity securities, principally common and preferred stocks of companies of any market capitalization.
Under normal market conditions, the fund invests at least 80% of its net assets, plus borrowings for investment purposes, in securities of companies principally engaged in the research, development, production, or distribution of products and services related to the health care industry ("health care companies").
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 19.60% |
| ASND | Ascendis Pharma AS | Healthcare | Biotechnology | 15.93% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 5.51% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 4.76% |
| PCVX | Vaxcyte Inc | Healthcare | Biotechnology | 4.62% |
| LEGN | Legend Biotech Corp | Healthcare | Biotechnology | 3.98% |
| RYTM | Rhythm Pharmaceuticals Inc | Healthcare | Biotechnology | 3.97% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 3.95% |
| SNY | Sanofi ADR | Healthcare | Drug Manufacturers - General | 3.55% |
| AAVXF | ABIVAX Société Anonyme | Healthcare | Biotechnology | 3.44% |
| HUM | Humana Inc | Healthcare | Healthcare Plans | 2.87% |
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 2.79% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 2.66% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 2.47% |
| 6XC | SOLENO THERAPEUT. DL-001 | Healthcare | Biotechnology | 2.39% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 2.33% |
| COR | Cencora Inc. | Healthcare | Medical Distribution | 2.33% |
| CVS | CVS Health Corp | Healthcare | Healthcare Plans | 2.32% |
| MLTX_old | Multex Com Inc | Other | Other | 2.25% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 1.96% |